Seeking Alpha

NuVasive (NUVA +5.7%) gets a bump from some positive comments out of JMP Securities today,...

NuVasive (NUVA +5.7%) gets a bump from some positive comments out of JMP Securities today, saying that after surveying top hospital executives, it believes that growth in spine surgery and back pain surgery is exceeding expectations. The firm notes that NUVA has little exposure to Europe, and ups its price target to $25 from $21.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)